𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Risperidone, haloperidol, and placebo in the treatment of aggressive challenging behaviour in patients with intellectual disability: a randomised controlled trial

✍ Scribed by Peter Tyrer; Patricia C Oliver-Africano; Zed Ahmed; Nick Bouras; Sherva Cooray; Shoumitro Deb; Declan Murphy; Monica Hare; Michael Meade; Ben Reece; Kofi Kramo; Sabyasachi Bhaumik; David Harley; Adrienne Regan; David Thomas; Bharti Rao; Bernard North; Joseph Eliahoo; Shamshad Karatela; Anju Soni; Mike Crawford

Book ID
117302313
Publisher
The Lancet
Year
2008
Tongue
English
Weight
143 KB
Volume
371
Category
Article
ISSN
0140-6736

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A double-blind randomised comparison of
A double-blind randomised comparison of risperidone and haloperidol in the treatment of behavioural and psychological symptoms in Chinese dementia patients
✍ Wai-chi Chan; Linda Chiu-wa Lam; Caroline Nga-pui Choy; Vivian Pui-yiu Leung; Si πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 76 KB πŸ‘ 1 views

## Abstract ## Background Behavioural and psychological symptoms (BPSD) are common during the course of dementia and present severe problems to patients and their caregivers. ## Objectives To assess the therapeutic efficacy and safety of haloperidol and risperidone in treating BPSD in Chinese de

Sodium valproate in the treatment of agg
Sodium valproate in the treatment of aggressive behavior in patients with dementiaβ€”a randomized placebo controlled clinical trial
✍ Rob C. Sival; P. M. Judith Haffmans; Paul A. F. Jansen; Sijmen A. Duursma; Piet πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 79 KB πŸ‘ 3 views

## Objectives: The efficacy and tolerability of sodium valproate 2 x 240 mg compared to placebo were investigated in aggressive behavior in dementia. ## Design: A randomized, placebo controlled, double-blind cross-over design. the trial included a baseline period (one week); a placebo period (thr